We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Warm and Cold Risks: How Temperature Variations Impact Mortality in Swedish Heart Failure Patients

MedXY Editorial Team•Oct 24, 2025•Cardiology
heart failureMortality

Introduction

Heart failure (HF) is a chronic and complex condition affecting millions worldwide, characterized by the heart’s inability to pump blood effectively. Patients with HF are particularly vulnerable to environmental stressors, including temperature extremes. Temperature fluctuations have been associated with adverse health outcomes, but the extent of their impact on HF patients, especially in high-latitude countries like Sweden, has not been fully elucidated.

In the context of climate variability and the ongoing global warming, understanding how short-term exposure to temperature variations influences mortality among HF patients is vital for developing targeted interventions. This article discusses a comprehensive nationwide study from Sweden, examining the associations between ambient temperature and mortality in this sensitive population.

Study Background and Clinical Relevance

Climate change has led to increased incidences of extreme weather events, including cold snaps and heatwaves. Patients with HF often have compromised cardiovascular resilience, making them susceptible to environmental stressors that can exacerbate their condition. Previous studies have shown associations between temperature and mortality in general populations; however, data specific to high-latitude populations and HF patients are scarce.

The clinical significance lies in the potential to inform physician guidance, public health policies, and climate adaptation strategies aimed at reducing temperature-related mortality in vulnerable groups.

Study Design and Methodology

This investigation was a nationwide, time-stratified case-crossover study conducted in Sweden, covering the years 2006 to 2021. The study population comprised 250,640 individuals with a diagnosis of HF who died during this period, identified via the Swedish National Patient Register and the Cause of Death Register.

Exposure assessment involved using daily mean ambient temperature data at a high-resolution 1 × 1 km spatial grid. To account for regional adaptation, temperature exposures were defined based on municipality-specific percentiles, with the 2.5th percentile indicating low temperatures and the 97.5th percentile representing high temperatures.

The primary outcomes were all-cause mortality and cardiovascular mortality. The case-crossover design enabled control for individual fixed characteristics, comparing each individual’s temperature exposure prior to death with control periods.

Key Findings and Results

The analysis revealed a U-shaped association between short-term ambient temperature and mortality among HF patients, indicating increased risk at both temperature extremes.

Over the entire study period, the odds ratio (OR) for all-cause mortality associated with low temperatures was 1.130 (95% CI, 1.074-1.189), suggesting a 13% increased risk. High temperatures were also associated with increased mortality, with an OR of 1.054 (95% CI, 1.017-1.093).

Similarly, for cardiovascular mortality, low temperatures showed a more pronounced risk with an OR of 1.160 (95% CI, 1.083-1.242). High temperatures’ association was significant mainly during 2014-2021, with an OR of 1.084 (95% CI, 1.014-1.159), and the risk appears to have increased over time.

Subgroup analyses indicated that male patients, individuals with diabetes, and diuretic users were more susceptible to low-temperature mortality. Conversely, high temperature posed a higher risk in patients with atrial fibrillation or flutter, especially when exposed to elevated ozone levels.

Expert Commentary

These findings underscore a critical public health concern: climate-related temperature fluctuations pose a significant risk to HF patients, even in colder high-latitude environments. The increasing mortality risk associated with high temperatures over time suggests that adaptation strategies—such as heat-health warning systems, patient education, and environmental modifications—are urgently needed.

Limitations include potential residual confounding factors, lack of individual behavior data (e.g., use of heating or cooling devices), and the observational nature of the study. Nonetheless, the robust nationwide data and high-resolution exposure assessment enhance the applicability of these results.

Mechanistically, temperature extremes can induce hemodynamic stress, dehydration, and inflammatory responses, aggravating heart failure decompensation. These insights support integrating climate considerations into HF management guidelines and public health planning.

Conclusions and Future Directions

Short-term exposure to both low and high ambient temperatures significantly increases mortality risk among Swedish patients with HF. The rising impact of heat exposure warrants strengthening adaptation strategies and personalized risk assessments. Future research should explore intervention efficacy, behavioral adaptations, and the role of environmental policies in mitigating temperature-related health risks.

This study highlights the urgent need for healthcare systems and policymakers to recognize climate change as a modifier of cardiovascular health. Protective strategies tailored to vulnerable populations can save lives and reduce healthcare burdens in the era of changing global temperatures.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Unraveling the Clinical Complexity of Extremely High NT-proBNP in Hospitalized Adults: Beyond Heart FailureExtremely high NT-proBNP levels in hospitalized patients often indicate infection rather than heart failure, with a high mortality risk; interpretation requires comprehensive clinical context.Sep 27, 2026Cardiac Resynchronization Therapy With or Without Atrioventricular Node Ablation in Atrial Fibrillation: The CAAN-AF TrialThis trial evaluated whether atrioventricular node ablation improves outcomes of cardiac resynchronization therapy in heart failure patients with permanent atrial fibrillation, finding no significant benefit over medical rate control.Sep 25, 2026Impact of Age at Type 1 Diabetes Onset on Mortality and Organ Complications: Insights from a Nationwide Swedish CohortYounger age at type 1 diabetes diagnosis significantly increases risks of mortality, cardiovascular, and kidney complications; each additional year delay in onset reduces these risks. This review synthesizes nationwide cohort findings and cSep 23, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Long-Term Quality of Life Outcomes in Older Patients Undergoing Heart Transplantation or Mechanical Circulatory Support: Insights from the SUSTAIN-IT Study
The SUSTAIN-IT study reveals variable improvements in health-related quality of life over two years following heart transplantation or long-term mechanical circulatory support in older heart failure patients, highlighting important consider
Sep 23, 2026
Pre-ICU Balanced Crystalloids Reduce Mortality in Sepsis: Insights from a Large Multicenter Cohort StudyA large multicenter study shows that balanced crystalloids administered before ICU admission in sepsis patients reduce 30-day mortality compared to saline, supporting early fluid choice’s impact on sepsis outcomes.Sep 23, 2026
Age, Anthracycline Use, and Mortality Outcomes in Classic Hodgkin Lymphoma: Insights from a Large Complete Population CohortThis review analyzes the impact of age and anthracycline-based chemotherapy on mortality in 28,000 classic Hodgkin lymphoma patients, highlighting poorer outcomes in the elderly and the therapeutic nuances influencing survival.Sep 21, 2026